Join to view full profile
171 Ashley AveCharleston, SC 29425
Phone+1 843-792-1414
Dr. Brescia is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1969 - 1970- Zucker School of Medicine at Hofstra/NorthwellInternship, Transitional Year, 1968 - 1969
Rutgers New Jersey Medical SchoolClass of 1968
Certifications & Licensure
NJ State Medical License 1974 - Present
SC State Medical License 1998 - 2027
GA State Medical License 1994 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
Clinical Trials
- Cisplatin, Bevacizumab, and Gemcitabine Followed by Surgery, Bevacizumab, and Paclitaxel in Treating Patients With Locally Advanced Nonmetastatic Bladder Cancer That Can Be Removed By Surgery Start of enrollment: 2005 Sep 21
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Dec 10
- Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers
Publications & Presentations
PubMed
- 2 citationsRechallenge of an alternative CDK 4/6 inhibitor after hepatotoxicity in the treatment of hormone-positive metastatic breast cancer.Kasey Jackson, Kiera Roubal, Christopher Rangel, Frank Brescia
Journal of Oncology Pharmacy Practice. 2025-10-01 - 91 citationsA Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade ...Sylvia Adams, Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh
Clinical Cancer Research. 2021-10-29 - 17 citationsA phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancerRamesh K. Ramanathan, Joel Picus, Haralambos Raftopoulos, Stephen A. Bernard, A. Craig Lockhart
Cancer Chemotherapy and Pharmacology. 2008-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
